Form 4: Twist Bioscience Corp Executive Sells Shares to Cover Tax Obligations

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 185 shares of common stock on February 3, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On February 3, 2025, Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, sold 185 shares of common stock.
• The sale was executed at a price of $49.352 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Werner directly owns 52,858 shares of Twist Bioscience Corp.
• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 7

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't indicate a change in the executive's outlook on the company.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who sell shares to cover tax obligations related to equity compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the reason for the sale.

Key Dates